MedTrace Logo

Swept Source OCT Imaging With the DREAM VG-OCT

NCT05876689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2024-11-25

No results posted yet for this study

Summary

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Conditions

Interventions

DEVICE

DREAM OCT

Swept Source OCT (similar to Zeiss Plex Elite)

Sponsors & Collaborators

  • Robert T. Chang, MD

    lead OTHER

Principal Investigators

  • Robert Chang, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2024-10-01
Completion
2024-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876689 on ClinicalTrials.gov